nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumethasone Pivalate—NR3C1—hematologic cancer	0.139	1	CbGaD
Flumethasone Pivalate—Betamethasone—hematologic cancer	0.119	0.336	CrCtD
Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.119	0.336	CrCtD
Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.116	0.328	CrCtD
Flumethasone Pivalate—SERPINA6—Triamcinolone—hematologic cancer	0.05	0.269	CbGbCtD
Flumethasone Pivalate—SERPINA6—Prednisolone—hematologic cancer	0.0424	0.228	CbGbCtD
Flumethasone Pivalate—NR3C1—Triamcinolone—hematologic cancer	0.0234	0.126	CbGbCtD
Flumethasone Pivalate—NR3C1—Betamethasone—hematologic cancer	0.0201	0.108	CbGbCtD
Flumethasone Pivalate—NR3C1—Prednisolone—hematologic cancer	0.0198	0.106	CbGbCtD
Flumethasone Pivalate—NR3C1—Prednisone—hematologic cancer	0.0187	0.101	CbGbCtD
Flumethasone Pivalate—NR3C1—Dexamethasone—hematologic cancer	0.0117	0.0627	CbGbCtD
Flumethasone Pivalate—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00368	0.0134	CrCrCtD
Flumethasone Pivalate—Fluticasone furoate—Betamethasone—hematologic cancer	0.00368	0.0134	CrCrCtD
Flumethasone Pivalate—Fluticasone furoate—Triamcinolone—hematologic cancer	0.0036	0.0131	CrCrCtD
Flumethasone Pivalate—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.0032	0.0116	CrCrCtD
Flumethasone Pivalate—Difluprednate—Betamethasone—hematologic cancer	0.0032	0.0116	CrCrCtD
Flumethasone Pivalate—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.0032	0.0116	CrCrCtD
Flumethasone Pivalate—Halobetasol Propionate—Betamethasone—hematologic cancer	0.0032	0.0116	CrCrCtD
Flumethasone Pivalate—Fluticasone Propionate—Betamethasone—hematologic cancer	0.0032	0.0116	CrCrCtD
Flumethasone Pivalate—Difluprednate—Dexamethasone—hematologic cancer	0.0032	0.0116	CrCrCtD
Flumethasone Pivalate—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00313	0.0114	CrCrCtD
Flumethasone Pivalate—Difluprednate—Triamcinolone—hematologic cancer	0.00313	0.0114	CrCrCtD
Flumethasone Pivalate—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00313	0.0114	CrCrCtD
Flumethasone Pivalate—Beclomethasone—Dexamethasone—hematologic cancer	0.00301	0.0109	CrCrCtD
Flumethasone Pivalate—Clocortolone—Betamethasone—hematologic cancer	0.00301	0.0109	CrCrCtD
Flumethasone Pivalate—Beclomethasone—Betamethasone—hematologic cancer	0.00301	0.0109	CrCrCtD
Flumethasone Pivalate—Clocortolone—Dexamethasone—hematologic cancer	0.00301	0.0109	CrCrCtD
Flumethasone Pivalate—Fluocinonide—Betamethasone—hematologic cancer	0.00301	0.0109	CrCrCtD
Flumethasone Pivalate—Fluocinonide—Dexamethasone—hematologic cancer	0.00301	0.0109	CrCrCtD
Flumethasone Pivalate—Beclomethasone—Triamcinolone—hematologic cancer	0.00294	0.0107	CrCrCtD
Flumethasone Pivalate—Fluocinonide—Triamcinolone—hematologic cancer	0.00294	0.0107	CrCrCtD
Flumethasone Pivalate—Clocortolone—Triamcinolone—hematologic cancer	0.00294	0.0107	CrCrCtD
Flumethasone Pivalate—Fluocortolone—Dexamethasone—hematologic cancer	0.00292	0.0106	CrCrCtD
Flumethasone Pivalate—Fluocortolone—Betamethasone—hematologic cancer	0.00292	0.0106	CrCrCtD
Flumethasone Pivalate—Fluocortolone—Triamcinolone—hematologic cancer	0.00286	0.0104	CrCrCtD
Flumethasone Pivalate—Alclometasone—Betamethasone—hematologic cancer	0.00284	0.0103	CrCrCtD
Flumethasone Pivalate—Alclometasone—Dexamethasone—hematologic cancer	0.00284	0.0103	CrCrCtD
Flumethasone Pivalate—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00284	0.0103	CrCrCtD
Flumethasone Pivalate—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00284	0.0103	CrCrCtD
Flumethasone Pivalate—Alclometasone—Triamcinolone—hematologic cancer	0.00278	0.0101	CrCrCtD
Flumethasone Pivalate—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00278	0.0101	CrCrCtD
Flumethasone Pivalate—Amcinonide—Betamethasone—hematologic cancer	0.00277	0.0101	CrCrCtD
Flumethasone Pivalate—Amcinonide—Dexamethasone—hematologic cancer	0.00277	0.0101	CrCrCtD
Flumethasone Pivalate—Beclomethasone—Prednisolone—hematologic cancer	0.00272	0.0099	CrCrCtD
Flumethasone Pivalate—Clocortolone—Prednisolone—hematologic cancer	0.00272	0.0099	CrCrCtD
Flumethasone Pivalate—Fluocortolone—Prednisone—hematologic cancer	0.00271	0.00985	CrCrCtD
Flumethasone Pivalate—Amcinonide—Triamcinolone—hematologic cancer	0.0027	0.00982	CrCrCtD
Flumethasone Pivalate—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00269	0.00979	CrCrCtD
Flumethasone Pivalate—Diflorasone—Dexamethasone—hematologic cancer	0.00269	0.00979	CrCrCtD
Flumethasone Pivalate—Diflorasone—Betamethasone—hematologic cancer	0.00269	0.00979	CrCrCtD
Flumethasone Pivalate—Flunisolide—Dexamethasone—hematologic cancer	0.00269	0.00979	CrCrCtD
Flumethasone Pivalate—Flunisolide—Betamethasone—hematologic cancer	0.00269	0.00979	CrCrCtD
Flumethasone Pivalate—Clobetasol propionate—Betamethasone—hematologic cancer	0.00269	0.00979	CrCrCtD
Flumethasone Pivalate—Fluocortolone—Prednisolone—hematologic cancer	0.00265	0.00962	CrCrCtD
Flumethasone Pivalate—Alclometasone—Prednisone—hematologic cancer	0.00264	0.00958	CrCrCtD
Flumethasone Pivalate—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00263	0.00957	CrCrCtD
Flumethasone Pivalate—Flunisolide—Triamcinolone—hematologic cancer	0.00263	0.00957	CrCrCtD
Flumethasone Pivalate—Diflorasone—Triamcinolone—hematologic cancer	0.00263	0.00957	CrCrCtD
Flumethasone Pivalate—Paramethasone—Dexamethasone—hematologic cancer	0.00263	0.00955	CrCrCtD
Flumethasone Pivalate—Paramethasone—Betamethasone—hematologic cancer	0.00263	0.00955	CrCrCtD
Flumethasone Pivalate—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00257	0.00935	CrCrCtD
Flumethasone Pivalate—Alclometasone—Prednisolone—hematologic cancer	0.00257	0.00935	CrCrCtD
Flumethasone Pivalate—Paramethasone—Triamcinolone—hematologic cancer	0.00257	0.00933	CrCrCtD
Flumethasone Pivalate—Amcinonide—Prednisone—hematologic cancer	0.00257	0.00932	CrCrCtD
Flumethasone Pivalate—Desoximetasone—Dexamethasone—hematologic cancer	0.00256	0.00932	CrCrCtD
Flumethasone Pivalate—Desoximetasone—Betamethasone—hematologic cancer	0.00256	0.00932	CrCrCtD
Flumethasone Pivalate—Desoximetasone—Triamcinolone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Amcinonide—Prednisolone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Fluorometholone—Betamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Mometasone—Betamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Mometasone—Dexamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Fluorometholone—Dexamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Triamcinolone—Dexamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Triamcinolone—Betamethasone—hematologic cancer	0.0025	0.0091	CrCrCtD
Flumethasone Pivalate—Diflorasone—Prednisone—hematologic cancer	0.0025	0.00908	CrCrCtD
Flumethasone Pivalate—Flunisolide—Prednisone—hematologic cancer	0.0025	0.00908	CrCrCtD
Flumethasone Pivalate—Clobetasol propionate—Prednisone—hematologic cancer	0.0025	0.00908	CrCrCtD
Flumethasone Pivalate—Rimexolone—Betamethasone—hematologic cancer	0.00245	0.00889	CrCrCtD
Flumethasone Pivalate—Rimexolone—Dexamethasone—hematologic cancer	0.00245	0.00889	CrCrCtD
Flumethasone Pivalate—Betamethasone—Dexamethasone—hematologic cancer	0.00245	0.00889	CrCrCtD
Flumethasone Pivalate—Dexamethasone—Betamethasone—hematologic cancer	0.00245	0.00889	CrCrCtD
Flumethasone Pivalate—Mometasone—Triamcinolone—hematologic cancer	0.00245	0.00889	CrCrCtD
Flumethasone Pivalate—Fluorometholone—Triamcinolone—hematologic cancer	0.00245	0.00889	CrCrCtD
Flumethasone Pivalate—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00245	0.00889	CrCrCtD
Flumethasone Pivalate—Diflorasone—Prednisolone—hematologic cancer	0.00244	0.00886	CrCrCtD
Flumethasone Pivalate—Flunisolide—Prednisolone—hematologic cancer	0.00244	0.00886	CrCrCtD
Flumethasone Pivalate—Clobetasol propionate—Prednisolone—hematologic cancer	0.00244	0.00886	CrCrCtD
Flumethasone Pivalate—Paramethasone—Prednisone—hematologic cancer	0.00244	0.00885	CrCrCtD
Flumethasone Pivalate—Dexamethasone—Triamcinolone—hematologic cancer	0.00239	0.00868	CrCrCtD
Flumethasone Pivalate—Rimexolone—Triamcinolone—hematologic cancer	0.00239	0.00868	CrCrCtD
Flumethasone Pivalate—Betamethasone—Triamcinolone—hematologic cancer	0.00239	0.00868	CrCrCtD
Flumethasone Pivalate—Paramethasone—Prednisolone—hematologic cancer	0.00238	0.00864	CrCrCtD
Flumethasone Pivalate—Desoximetasone—Prednisone—hematologic cancer	0.00238	0.00864	CrCrCtD
Flumethasone Pivalate—Methylprednisolone—Betamethasone—hematologic cancer	0.00234	0.0085	CrCrCtD
Flumethasone Pivalate—Methylprednisolone—Dexamethasone—hematologic cancer	0.00234	0.0085	CrCrCtD
Flumethasone Pivalate—Triamcinolone—Prednisone—hematologic cancer	0.00232	0.00843	CrCrCtD
Flumethasone Pivalate—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00232	0.00843	CrCrCtD
Flumethasone Pivalate—Mometasone—Prednisone—hematologic cancer	0.00232	0.00843	CrCrCtD
Flumethasone Pivalate—Fluorometholone—Prednisone—hematologic cancer	0.00232	0.00843	CrCrCtD
Flumethasone Pivalate—Desoximetasone—Prednisolone—hematologic cancer	0.00232	0.00843	CrCrCtD
Flumethasone Pivalate—Methylprednisolone—Triamcinolone—hematologic cancer	0.00229	0.00831	CrCrCtD
Flumethasone Pivalate—Dexamethasone—Prednisone—hematologic cancer	0.00227	0.00824	CrCrCtD
Flumethasone Pivalate—Betamethasone—Prednisone—hematologic cancer	0.00227	0.00824	CrCrCtD
Flumethasone Pivalate—Rimexolone—Prednisone—hematologic cancer	0.00227	0.00824	CrCrCtD
Flumethasone Pivalate—Fluorometholone—Prednisolone—hematologic cancer	0.00227	0.00823	CrCrCtD
Flumethasone Pivalate—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00227	0.00823	CrCrCtD
Flumethasone Pivalate—Mometasone—Prednisolone—hematologic cancer	0.00227	0.00823	CrCrCtD
Flumethasone Pivalate—Triamcinolone—Prednisolone—hematologic cancer	0.00227	0.00823	CrCrCtD
Flumethasone Pivalate—Rimexolone—Prednisolone—hematologic cancer	0.00221	0.00804	CrCrCtD
Flumethasone Pivalate—Betamethasone—Prednisolone—hematologic cancer	0.00221	0.00804	CrCrCtD
Flumethasone Pivalate—Dexamethasone—Prednisolone—hematologic cancer	0.00221	0.00804	CrCrCtD
Flumethasone Pivalate—Methylprednisolone—Prednisone—hematologic cancer	0.00217	0.00788	CrCrCtD
Flumethasone Pivalate—Methylprednisolone—Prednisolone—hematologic cancer	0.00212	0.00769	CrCrCtD
Flumethasone Pivalate—Burning sensation—Nelarabine—hematologic cancer	0.00103	0.0441	CcSEcCtD
Flumethasone Pivalate—Sensitisation—Alitretinoin—hematologic cancer	0.000977	0.0418	CcSEcCtD
Flumethasone Pivalate—Burning sensation—Idarubicin—hematologic cancer	0.000927	0.0396	CcSEcCtD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—RFXANK—hematologic cancer	0.000785	0.0406	CbGpPWpGaD
Flumethasone Pivalate—Burning sensation—Lenalidomide—hematologic cancer	0.000636	0.0272	CcSEcCtD
Flumethasone Pivalate—Burning sensation—Thalidomide—hematologic cancer	0.000528	0.0226	CcSEcCtD
Flumethasone Pivalate—Burning sensation—Carmustine—hematologic cancer	0.000507	0.0217	CcSEcCtD
Flumethasone Pivalate—Sensitisation—Epirubicin—hematologic cancer	0.000428	0.0183	CcSEcCtD
Flumethasone Pivalate—Sensitisation—Doxorubicin—hematologic cancer	0.000396	0.0169	CcSEcCtD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY2—hematologic cancer	0.000391	0.0203	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY1—hematologic cancer	0.000391	0.0203	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER2—hematologic cancer	0.000391	0.0203	CbGpPWpGaD
Flumethasone Pivalate—SERPINA6—hematopoietic system—hematologic cancer	0.000391	0.204	CbGeAlD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—hematologic cancer	0.000341	0.0176	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—hematologic cancer	0.000341	0.0176	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—HDAC11—hematologic cancer	0.000326	0.0169	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—GATA2—hematologic cancer	0.000301	0.0156	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER1—hematologic cancer	0.000297	0.0153	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Ruxolitinib—hematologic cancer	0.000295	0.0126	CcSEcCtD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—HDAC10—hematologic cancer	0.00029	0.015	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—PER2—hematologic cancer	0.000285	0.0147	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—CRY1—hematologic cancer	0.000285	0.0147	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—CRY2—hematologic cancer	0.000285	0.0147	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—BCL6—hematologic cancer	0.000273	0.0141	CbGpPWpGaD
Flumethasone Pivalate—SERPINA6—blood—hematologic cancer	0.000259	0.135	CbGeAlD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—GATA1—hematologic cancer	0.000259	0.0134	CbGpPWpGaD
Flumethasone Pivalate—SERPINA6—bone marrow—hematologic cancer	0.000251	0.131	CbGeAlD
Flumethasone Pivalate—Pruritus—Vorinostat—hematologic cancer	0.00025	0.0107	CcSEcCtD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—RARA—hematologic cancer	0.000237	0.0122	CbGpPWpGaD
Flumethasone Pivalate—Burning sensation—Methotrexate—hematologic cancer	0.000235	0.01	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—GATA2—hematologic cancer	0.00023	0.0119	CbGpPWpGaD
Flumethasone Pivalate—SERPINA6—lung—hematologic cancer	0.000227	0.119	CbGeAlD
Flumethasone Pivalate—Hypersensitivity—Mechlorethamine—hematologic cancer	0.000223	0.00954	CcSEcCtD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—PBX1—hematologic cancer	0.000223	0.0115	CbGpPWpGaD
Flumethasone Pivalate—Burning sensation—Epirubicin—hematologic cancer	0.00022	0.00939	CcSEcCtD
Flumethasone Pivalate—NR3C1—Circadian Clock—PER1—hematologic cancer	0.000216	0.0112	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Mechlorethamine—hematologic cancer	0.000214	0.00916	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—DUSP5—hematologic cancer	0.000214	0.0111	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—hematologic cancer	0.000213	0.011	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—hematologic cancer	0.000211	0.0109	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CBFB—hematologic cancer	0.000209	0.0108	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—MAF—hematologic cancer	0.000209	0.0108	CbGpPWpGaD
Flumethasone Pivalate—Burning sensation—Doxorubicin—hematologic cancer	0.000203	0.00869	CcSEcCtD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—NCOR2—hematologic cancer	0.000199	0.0103	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—hematologic cancer	0.000196	0.0101	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—hematologic cancer	0.000196	0.0101	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.000192	0.00994	CbGpPWpGaD
Flumethasone Pivalate—Rash—Mechlorethamine—hematologic cancer	0.000191	0.00817	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Mechlorethamine—hematologic cancer	0.000191	0.00816	CcSEcCtD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—SUMO1—hematologic cancer	0.000187	0.00968	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—RARA—hematologic cancer	0.000187	0.00968	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CBFB—hematologic cancer	0.000186	0.00964	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—SPI1—hematologic cancer	0.000185	0.00955	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—GATA2—hematologic cancer	0.000184	0.00954	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Methoxsalen—hematologic cancer	0.000184	0.00786	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—EOMES—hematologic cancer	0.000182	0.00943	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—hematologic cancer	0.000181	0.00938	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Mercaptopurine—hematologic cancer	0.000179	0.00764	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TCF3—hematologic cancer	0.000178	0.0092	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Methoxsalen—hematologic cancer	0.000177	0.00755	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Daunorubicin—hematologic cancer	0.000176	0.00753	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Clofarabine—hematologic cancer	0.000176	0.00753	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Pentostatin—hematologic cancer	0.000176	0.0075	CcSEcCtD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hematologic cancer	0.000174	0.009	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—hematopoietic system—hematologic cancer	0.000171	0.0895	CbGeAlD
Flumethasone Pivalate—Pruritus—Clofarabine—hematologic cancer	0.000169	0.00723	CcSEcCtD
Flumethasone Pivalate—Pruritus—Daunorubicin—hematologic cancer	0.000169	0.00723	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Idarubicin—hematologic cancer	0.000169	0.00723	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—CEBPA—hematologic cancer	0.000169	0.00872	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Anagrelide—hematologic cancer	0.000169	0.0072	CcSEcCtD
Flumethasone Pivalate—Pruritus—Pentostatin—hematologic cancer	0.000169	0.0072	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Teniposide—hematologic cancer	0.000165	0.00704	CcSEcCtD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—hematologic cancer	0.00016	0.00825	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Teniposide—hematologic cancer	0.000158	0.00676	CcSEcCtD
Flumethasone Pivalate—Rash—Methoxsalen—hematologic cancer	0.000158	0.00673	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Methoxsalen—hematologic cancer	0.000157	0.00672	CcSEcCtD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—NUP214—hematologic cancer	0.000156	0.00806	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—ARNTL—hematologic cancer	0.000154	0.00796	CbGpPWpGaD
Flumethasone Pivalate—Rash—Mercaptopurine—hematologic cancer	0.000153	0.00654	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Mercaptopurine—hematologic cancer	0.000153	0.00653	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Busulfan—hematologic cancer	0.000153	0.00652	CcSEcCtD
Flumethasone Pivalate—Rash—Daunorubicin—hematologic cancer	0.000151	0.00645	CcSEcCtD
Flumethasone Pivalate—Rash—Clofarabine—hematologic cancer	0.000151	0.00645	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Clofarabine—hematologic cancer	0.000151	0.00644	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Daunorubicin—hematologic cancer	0.000151	0.00644	CcSEcCtD
Flumethasone Pivalate—Rash—Pentostatin—hematologic cancer	0.00015	0.00642	CcSEcCtD
Flumethasone Pivalate—Rash—Anagrelide—hematologic cancer	0.00015	0.00642	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Pentostatin—hematologic cancer	0.00015	0.00641	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Anagrelide—hematologic cancer	0.00015	0.00641	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Procarbazine—hematologic cancer	0.000148	0.00633	CcSEcCtD
Flumethasone Pivalate—Pruritus—Busulfan—hematologic cancer	0.000147	0.00626	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Bexarotene—hematologic cancer	0.000145	0.0062	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Dasatinib—hematologic cancer	0.000145	0.0062	CcSEcCtD
Flumethasone Pivalate—Rash—Idarubicin—hematologic cancer	0.000145	0.00619	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Idarubicin—hematologic cancer	0.000145	0.00618	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Fludarabine—hematologic cancer	0.000145	0.00618	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—EBF1—hematologic cancer	0.000143	0.00741	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Procarbazine—hematologic cancer	0.000142	0.00607	CcSEcCtD
Flumethasone Pivalate—Rash—Teniposide—hematologic cancer	0.000141	0.00602	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Teniposide—hematologic cancer	0.000141	0.00602	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—LEF1—hematologic cancer	0.000141	0.00727	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—hematologic cancer	0.000139	0.00721	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Dasatinib—hematologic cancer	0.000139	0.00595	CcSEcCtD
Flumethasone Pivalate—Pruritus—Bexarotene—hematologic cancer	0.000139	0.00595	CcSEcCtD
Flumethasone Pivalate—Pruritus—Fludarabine—hematologic cancer	0.000139	0.00594	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Chlorambucil—hematologic cancer	0.000137	0.00586	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Nilotinib—hematologic cancer	0.000134	0.00573	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Imatinib—hematologic cancer	0.000133	0.0057	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000133	0.00689	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Chlorambucil—hematologic cancer	0.000132	0.00563	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Cladribine—hematologic cancer	0.000131	0.0056	CcSEcCtD
Flumethasone Pivalate—Rash—Busulfan—hematologic cancer	0.000131	0.00558	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Busulfan—hematologic cancer	0.00013	0.00557	CcSEcCtD
Flumethasone Pivalate—NR3C1—gonad—hematologic cancer	0.00013	0.068	CbGeAlD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—hematologic cancer	0.000129	0.00668	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Nilotinib—hematologic cancer	0.000129	0.0055	CcSEcCtD
Flumethasone Pivalate—Pruritus—Imatinib—hematologic cancer	0.000128	0.00547	CcSEcCtD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hematologic cancer	0.000128	0.00662	CbGpPWpGaD
Flumethasone Pivalate—Rash—Procarbazine—hematologic cancer	0.000127	0.00541	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Procarbazine—hematologic cancer	0.000127	0.00541	CcSEcCtD
Flumethasone Pivalate—Pruritus—Cladribine—hematologic cancer	0.000126	0.00537	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Vinblastine—hematologic cancer	0.000126	0.00537	CcSEcCtD
Flumethasone Pivalate—Rash—Dasatinib—hematologic cancer	0.000124	0.00531	CcSEcCtD
Flumethasone Pivalate—Rash—Bexarotene—hematologic cancer	0.000124	0.00531	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Dasatinib—hematologic cancer	0.000124	0.0053	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Bexarotene—hematologic cancer	0.000124	0.0053	CcSEcCtD
Flumethasone Pivalate—Rash—Fludarabine—hematologic cancer	0.000124	0.00529	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—REL—hematologic cancer	0.000124	0.0064	CbGpPWpGaD
Flumethasone Pivalate—Dermatitis—Fludarabine—hematologic cancer	0.000124	0.00529	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—ID3—hematologic cancer	0.000122	0.0063	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—hematologic cancer	0.000121	0.00626	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Melphalan—hematologic cancer	0.00012	0.00511	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Lenalidomide—hematologic cancer	0.000116	0.00496	CcSEcCtD
Flumethasone Pivalate—Pruritus—Melphalan—hematologic cancer	0.000115	0.0049	CcSEcCtD
Flumethasone Pivalate—Rash—Nilotinib—hematologic cancer	0.000115	0.0049	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Nilotinib—hematologic cancer	0.000115	0.0049	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000115	0.0049	CcSEcCtD
Flumethasone Pivalate—Rash—Imatinib—hematologic cancer	0.000114	0.00488	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Imatinib—hematologic cancer	0.000114	0.00487	CcSEcCtD
Flumethasone Pivalate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—hematologic cancer	0.000114	0.00588	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—blood—hematologic cancer	0.000113	0.0593	CbGeAlD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—hematologic cancer	0.000113	0.00587	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—GATA2—hematologic cancer	0.000112	0.00581	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—hematologic cancer	0.000112	0.00581	CbGpPWpGaD
Flumethasone Pivalate—Rash—Cladribine—hematologic cancer	0.000112	0.00479	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Cladribine—hematologic cancer	0.000112	0.00479	CcSEcCtD
Flumethasone Pivalate—Pruritus—Lenalidomide—hematologic cancer	0.000112	0.00477	CcSEcCtD
Flumethasone Pivalate—NR3C1—bone marrow—hematologic cancer	0.00011	0.0574	CbGeAlD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—JUND—hematologic cancer	0.000108	0.00558	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Bortezomib—hematologic cancer	0.000107	0.00457	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Bleomycin—hematologic cancer	0.000106	0.00453	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—MYB—hematologic cancer	0.000106	0.00548	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—hematologic cancer	0.000106	0.00547	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—AR—hematologic cancer	0.000106	0.00547	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.000105	0.00545	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Vinorelbine—hematologic cancer	0.000104	0.00446	CcSEcCtD
Flumethasone Pivalate—Pruritus—Bortezomib—hematologic cancer	0.000103	0.00439	CcSEcCtD
Flumethasone Pivalate—Rash—Melphalan—hematologic cancer	0.000102	0.00437	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—DKK1—hematologic cancer	0.000102	0.00529	CbGpPWpGaD
Flumethasone Pivalate—Dermatitis—Melphalan—hematologic cancer	0.000102	0.00437	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	0.000102	0.00528	CbGpPWpGaD
Flumethasone Pivalate—Difluprednate—NR3C1—hematologic cancer	0.000102	0.0656	CrCbGaD
Flumethasone Pivalate—Pruritus—Bleomycin—hematologic cancer	0.000102	0.00435	CcSEcCtD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—CREB1—hematologic cancer	0.000101	0.00523	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Vinorelbine—hematologic cancer	0.0001	0.00428	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Thiotepa—hematologic cancer	9.97e-05	0.00426	CcSEcCtD
Flumethasone Pivalate—Rash—Lenalidomide—hematologic cancer	9.94e-05	0.00425	CcSEcCtD
Flumethasone Pivalate—NR3C1—lung—hematologic cancer	9.94e-05	0.052	CbGeAlD
Flumethasone Pivalate—Dermatitis—Lenalidomide—hematologic cancer	9.94e-05	0.00425	CcSEcCtD
Flumethasone Pivalate—Clocortolone—NR3C1—hematologic cancer	9.89e-05	0.0636	CrCbGaD
Flumethasone Pivalate—Rash—Hydroxyurea—hematologic cancer	9.81e-05	0.00419	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Hydroxyurea—hematologic cancer	9.8e-05	0.00419	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	9.71e-05	0.00503	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Thalidomide—hematologic cancer	9.64e-05	0.00412	CcSEcCtD
Flumethasone Pivalate—Pruritus—Thiotepa—hematologic cancer	9.57e-05	0.00409	CcSEcCtD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—hematologic cancer	9.44e-05	0.00488	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—testis—hematologic cancer	9.38e-05	0.049	CbGeAlD
Flumethasone Pivalate—Diflorasone—NR3C1—hematologic cancer	9.36e-05	0.0602	CrCbGaD
Flumethasone Pivalate—Hypersensitivity—Carmustine—hematologic cancer	9.26e-05	0.00396	CcSEcCtD
Flumethasone Pivalate—Pruritus—Thalidomide—hematologic cancer	9.26e-05	0.00396	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Alitretinoin—hematologic cancer	9.18e-05	0.00392	CcSEcCtD
Flumethasone Pivalate—Rash—Bortezomib—hematologic cancer	9.15e-05	0.00391	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Bortezomib—hematologic cancer	9.14e-05	0.00391	CcSEcCtD
Flumethasone Pivalate—Desoximetasone—NR3C1—hematologic cancer	9.13e-05	0.0587	CrCbGaD
Flumethasone Pivalate—Rash—Bleomycin—hematologic cancer	9.08e-05	0.00388	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Bleomycin—hematologic cancer	9.07e-05	0.00388	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Ifosfamide—hematologic cancer	9.07e-05	0.00387	CcSEcCtD
Flumethasone Pivalate—Rash—Vinorelbine—hematologic cancer	8.94e-05	0.00382	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Vinorelbine—hematologic cancer	8.93e-05	0.00381	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—PTHLH—hematologic cancer	8.9e-05	0.00461	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—RARA—hematologic cancer	8.85e-05	0.00458	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Vincristine—hematologic cancer	8.84e-05	0.00378	CcSEcCtD
Flumethasone Pivalate—Pruritus—Alitretinoin—hematologic cancer	8.81e-05	0.00376	CcSEcCtD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—STAT5B—hematologic cancer	8.73e-05	0.00452	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Ifosfamide—hematologic cancer	8.71e-05	0.00372	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	8.69e-05	0.00449	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Irinotecan—hematologic cancer	8.61e-05	0.00368	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Mitoxantrone—hematologic cancer	8.61e-05	0.00368	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—RET—hematologic cancer	8.58e-05	0.00444	CbGpPWpGaD
Flumethasone Pivalate—Rash—Thiotepa—hematologic cancer	8.53e-05	0.00365	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Thiotepa—hematologic cancer	8.53e-05	0.00364	CcSEcCtD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—AR—hematologic cancer	8.36e-05	0.00432	CbGpPWpGaD
Flumethasone Pivalate—Rash—Thalidomide—hematologic cancer	8.25e-05	0.00353	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Thalidomide—hematologic cancer	8.25e-05	0.00352	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—CEBPD—hematologic cancer	8.23e-05	0.00426	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—CEBPA—hematologic cancer	8.23e-05	0.00426	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—ZNF552—hematologic cancer	8.12e-05	0.0042	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—EZH2—hematologic cancer	8.11e-05	0.00419	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—AR—hematologic cancer	8.1e-05	0.00419	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Gemcitabine—hematologic cancer	8.05e-05	0.00344	CcSEcCtD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—hematologic cancer	8.03e-05	0.00416	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—IL13—hematologic cancer	7.99e-05	0.00413	CbGpPWpGaD
Flumethasone Pivalate—Rash—Carmustine—hematologic cancer	7.93e-05	0.00339	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Carmustine—hematologic cancer	7.92e-05	0.00338	CcSEcCtD
Flumethasone Pivalate—Rash—Alitretinoin—hematologic cancer	7.85e-05	0.00336	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Alitretinoin—hematologic cancer	7.85e-05	0.00335	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Cisplatin—hematologic cancer	7.82e-05	0.00334	CcSEcCtD
Flumethasone Pivalate—Rash—Ifosfamide—hematologic cancer	7.76e-05	0.00332	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Ifosfamide—hematologic cancer	7.75e-05	0.00331	CcSEcCtD
Flumethasone Pivalate—Halobetasol Propionate—NR3C1—hematologic cancer	7.73e-05	0.0497	CrCbGaD
Flumethasone Pivalate—Rash—Vincristine—hematologic cancer	7.57e-05	0.00323	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Vincristine—hematologic cancer	7.56e-05	0.00323	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—NCOR2—hematologic cancer	7.43e-05	0.00384	CbGpPWpGaD
Flumethasone Pivalate—Rash—Mitoxantrone—hematologic cancer	7.37e-05	0.00315	CcSEcCtD
Flumethasone Pivalate—Rash—Irinotecan—hematologic cancer	7.37e-05	0.00315	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Mitoxantrone—hematologic cancer	7.36e-05	0.00315	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Irinotecan—hematologic cancer	7.36e-05	0.00315	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	7.28e-05	0.00376	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	7.26e-05	0.00376	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	7.26e-05	0.00376	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	7.21e-05	0.00373	CbGpPWpGaD
Flumethasone Pivalate—Amcinonide—NR3C1—hematologic cancer	7.19e-05	0.0462	CrCbGaD
Flumethasone Pivalate—Rash—Gemcitabine—hematologic cancer	7.18e-05	0.00307	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Gemcitabine—hematologic cancer	7.17e-05	0.00306	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Etoposide—hematologic cancer	7.16e-05	0.00306	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Prednisolone—hematologic cancer	7.06e-05	0.00302	CcSEcCtD
Flumethasone Pivalate—Fluticasone furoate—NR3C1—hematologic cancer	7.05e-05	0.0453	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	6.9e-05	0.00357	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	6.88e-05	0.00356	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Etoposide—hematologic cancer	6.88e-05	0.00294	CcSEcCtD
Flumethasone Pivalate—NR3C1—Circadian Clock—NCOR1—hematologic cancer	6.88e-05	0.00356	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	6.86e-05	0.00355	CbGpPWpGaD
Flumethasone Pivalate—Mometasone—NR3C1—hematologic cancer	6.84e-05	0.044	CrCbGaD
Flumethasone Pivalate—NR3C1—lymph node—hematologic cancer	6.8e-05	0.0355	CbGeAlD
Flumethasone Pivalate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	6.76e-05	0.0035	CbGpPWpGaD
Flumethasone Pivalate—Rimexolone—NR3C1—hematologic cancer	6.76e-05	0.0434	CrCbGaD
Flumethasone Pivalate—Rash—Cisplatin—hematologic cancer	6.69e-05	0.00286	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Cisplatin—hematologic cancer	6.68e-05	0.00286	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	6.66e-05	0.00344	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	6.59e-05	0.00341	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	6.5e-05	0.00336	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Triamcinolone—hematologic cancer	6.5e-05	0.00278	CcSEcCtD
Flumethasone Pivalate—Beclomethasone—NR3C1—hematologic cancer	6.37e-05	0.041	CrCbGaD
Flumethasone Pivalate—Fluocinonide—NR3C1—hematologic cancer	6.37e-05	0.041	CrCbGaD
Flumethasone Pivalate—Pruritus—Triamcinolone—hematologic cancer	6.24e-05	0.00267	CcSEcCtD
Flumethasone Pivalate—Fluocinolone Acetonide—NR3C1—hematologic cancer	6.19e-05	0.0398	CrCbGaD
Flumethasone Pivalate—Alclometasone—NR3C1—hematologic cancer	6.19e-05	0.0398	CrCbGaD
Flumethasone Pivalate—Rash—Etoposide—hematologic cancer	6.13e-05	0.00262	CcSEcCtD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	6.13e-05	0.00317	CbGpPWpGaD
Flumethasone Pivalate—Dermatitis—Etoposide—hematologic cancer	6.12e-05	0.00262	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	6.05e-05	0.00313	CbGpPWpGaD
Flumethasone Pivalate—Rash—Prednisolone—hematologic cancer	6.05e-05	0.00258	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Prednisolone—hematologic cancer	6.04e-05	0.00258	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—STAT5B—hematologic cancer	6.04e-05	0.00312	CbGpPWpGaD
Flumethasone Pivalate—Flunisolide—NR3C1—hematologic cancer	6.03e-05	0.0388	CrCbGaD
Flumethasone Pivalate—Clobetasol propionate—NR3C1—hematologic cancer	6.03e-05	0.0388	CrCbGaD
Flumethasone Pivalate—Paramethasone—NR3C1—hematologic cancer	5.96e-05	0.0383	CrCbGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	5.91e-05	0.00306	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	5.86e-05	0.00303	CbGpPWpGaD
Flumethasone Pivalate—Fluorometholone—NR3C1—hematologic cancer	5.81e-05	0.0374	CrCbGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	5.81e-05	0.00301	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	5.8e-05	0.003	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	5.77e-05	0.00299	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	5.74e-05	0.00297	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	5.67e-05	0.00293	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	5.67e-05	0.00293	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Betamethasone—hematologic cancer	5.66e-05	0.00242	CcSEcCtD
Flumethasone Pivalate—Pruritus—Dexamethasone—hematologic cancer	5.66e-05	0.00242	CcSEcCtD
Flumethasone Pivalate—Methylprednisolone—NR3C1—hematologic cancer	5.62e-05	0.0361	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	5.61e-05	0.0029	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	5.58e-05	0.00289	CbGpPWpGaD
Flumethasone Pivalate—Rash—Triamcinolone—hematologic cancer	5.56e-05	0.00238	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Triamcinolone—hematologic cancer	5.55e-05	0.00237	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	5.51e-05	0.00285	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	5.45e-05	0.00282	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	5.32e-05	0.00275	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	5.31e-05	0.00275	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	5.3e-05	0.00274	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Prednisone—hematologic cancer	5.13e-05	0.00219	CcSEcCtD
Flumethasone Pivalate—Rash—Betamethasone—hematologic cancer	5.04e-05	0.00216	CcSEcCtD
Flumethasone Pivalate—Rash—Dexamethasone—hematologic cancer	5.04e-05	0.00216	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	5.04e-05	0.00261	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	5.04e-05	0.00261	CbGpPWpGaD
Flumethasone Pivalate—Dermatitis—Betamethasone—hematologic cancer	5.04e-05	0.00215	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Dexamethasone—hematologic cancer	5.04e-05	0.00215	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	5e-05	0.00258	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—GATA3—hematologic cancer	4.98e-05	0.00258	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	4.94e-05	0.00256	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Prednisone—hematologic cancer	4.93e-05	0.00211	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	4.92e-05	0.00254	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	4.88e-05	0.00252	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	4.87e-05	0.00252	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—CREB1—hematologic cancer	4.86e-05	0.00251	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	4.86e-05	0.00251	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	4.77e-05	0.00247	CbGpPWpGaD
Flumethasone Pivalate—Triamcinolone—NR3C1—hematologic cancer	4.74e-05	0.0305	CrCbGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—CREBBP—hematologic cancer	4.73e-05	0.00245	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	4.45e-05	0.0023	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	4.43e-05	0.00229	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	4.41e-05	0.00228	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	4.4e-05	0.00227	CbGpPWpGaD
Flumethasone Pivalate—Rash—Prednisone—hematologic cancer	4.39e-05	0.00188	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Prednisone—hematologic cancer	4.39e-05	0.00188	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	4.31e-05	0.00223	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Methotrexate—hematologic cancer	4.29e-05	0.00183	CcSEcCtD
Flumethasone Pivalate—Fluticasone Propionate—NR3C1—hematologic cancer	4.24e-05	0.0272	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	4.21e-05	0.00218	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	4.14e-05	0.00214	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Methotrexate—hematologic cancer	4.12e-05	0.00176	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—STAT1—hematologic cancer	4.09e-05	0.00211	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Epirubicin—hematologic cancer	4.01e-05	0.00172	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	4.01e-05	0.00208	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	4.01e-05	0.00207	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	4e-05	0.00207	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	3.98e-05	0.00206	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	3.96e-05	0.00205	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	3.92e-05	0.00203	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—ZNF552—hematologic cancer	3.91e-05	0.00202	CbGpPWpGaD
Flumethasone Pivalate—Betamethasone—NR3C1—hematologic cancer	3.88e-05	0.025	CrCbGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	3.86e-05	0.002	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Epirubicin—hematologic cancer	3.86e-05	0.00165	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Doxorubicin—hematologic cancer	3.71e-05	0.00159	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—STAT5A—hematologic cancer	3.67e-05	0.0019	CbGpPWpGaD
Flumethasone Pivalate—Rash—Methotrexate—hematologic cancer	3.67e-05	0.00157	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Methotrexate—hematologic cancer	3.67e-05	0.00157	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	3.6e-05	0.00186	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	3.57e-05	0.00185	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Doxorubicin—hematologic cancer	3.57e-05	0.00152	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	3.57e-05	0.00184	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	3.54e-05	0.00183	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	3.53e-05	0.00183	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	3.47e-05	0.0018	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—NCOR1—hematologic cancer	3.46e-05	0.00179	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	3.44e-05	0.00178	CbGpPWpGaD
Flumethasone Pivalate—Rash—Epirubicin—hematologic cancer	3.44e-05	0.00147	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Epirubicin—hematologic cancer	3.43e-05	0.00147	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	3.42e-05	0.00177	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	3.42e-05	0.00177	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	3.41e-05	0.00176	CbGpPWpGaD
Flumethasone Pivalate—Fluticasone furoate—ABCB1—hematologic cancer	3.4e-05	0.0219	CrCbGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—FOXO1—hematologic cancer	3.37e-05	0.00174	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	3.33e-05	0.00172	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	3.32e-05	0.00172	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	3.23e-05	0.00167	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	3.23e-05	0.00167	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—EP300—hematologic cancer	3.22e-05	0.00167	CbGpPWpGaD
Flumethasone Pivalate—Rash—Doxorubicin—hematologic cancer	3.18e-05	0.00136	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Doxorubicin—hematologic cancer	3.18e-05	0.00136	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—FAS—hematologic cancer	3.1e-05	0.0016	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	3.03e-05	0.00157	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	3e-05	0.00155	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	3e-05	0.00155	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.99e-05	0.00154	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.96e-05	0.00153	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—CASC3—hematologic cancer	2.96e-05	0.00153	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.94e-05	0.00152	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.92e-05	0.00151	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.89e-05	0.00149	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.88e-05	0.00149	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	2.79e-05	0.00144	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	2.71e-05	0.0014	CbGpPWpGaD
Flumethasone Pivalate—Methylprednisolone—ABCB1—hematologic cancer	2.71e-05	0.0174	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	2.66e-05	0.00138	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—ABCG2—hematologic cancer	2.62e-05	0.0168	CrCbGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	2.61e-05	0.00135	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	2.56e-05	0.00133	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	2.54e-05	0.00131	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	2.49e-05	0.00129	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	2.46e-05	0.00127	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—CREB1—hematologic cancer	2.44e-05	0.00126	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	2.4e-05	0.00124	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—RB1—hematologic cancer	2.37e-05	0.00123	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	2.37e-05	0.00122	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	2.36e-05	0.00122	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	2.34e-05	0.00121	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.33e-05	0.0012	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	2.32e-05	0.0012	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	2.31e-05	0.0012	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—NR3C1—hematologic cancer	2.26e-05	0.0145	CrCbGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	2.11e-05	0.00109	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	2.1e-05	0.00109	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	2.06e-05	0.00107	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	2.06e-05	0.00107	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	2.06e-05	0.00106	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RARS—hematologic cancer	1.91e-05	0.000987	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.9e-05	0.000984	CbGpPWpGaD
Flumethasone Pivalate—Betamethasone—ABCB1—hematologic cancer	1.87e-05	0.012	CrCbGaD
Flumethasone Pivalate—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.79e-05	0.000928	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.74e-05	0.000901	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.73e-05	0.000893	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.7e-05	0.000881	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.68e-05	0.000867	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.57e-05	0.00081	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.56e-05	0.000808	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RARA—hematologic cancer	1.56e-05	0.000805	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—TET2—hematologic cancer	1.56e-05	0.000805	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.53e-05	0.000794	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.53e-05	0.000789	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.52e-05	0.000786	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.52e-05	0.000785	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.45e-05	0.000748	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.44e-05	0.000747	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.43e-05	0.000739	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.42e-05	0.000732	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.41e-05	0.000729	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.4e-05	0.000724	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.38e-05	0.000714	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—ELL—hematologic cancer	1.36e-05	0.000703	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.33e-05	0.000688	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.33e-05	0.000686	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—TNF—hematologic cancer	1.31e-05	0.00068	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NCOR2—hematologic cancer	1.31e-05	0.000675	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	1.26e-05	0.000653	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—AGO2—hematologic cancer	1.2e-05	0.000623	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—DNMT3B—hematologic cancer	1.18e-05	0.00061	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—H3F3B—hematologic cancer	1.18e-05	0.00061	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.14e-05	0.000588	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—ABCB1—hematologic cancer	1.09e-05	0.007	CrCbGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RPS14—hematologic cancer	1.08e-05	0.000558	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NUP98—hematologic cancer	1.06e-05	0.000549	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—IL6—hematologic cancer	1.06e-05	0.000549	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NUP214—hematologic cancer	1.02e-05	0.000529	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	9.91e-06	0.000513	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	9.58e-06	0.000496	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	9.43e-06	0.000488	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—HSPB1—hematologic cancer	9.43e-06	0.000488	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	9.17e-06	0.000474	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—SMC1A—hematologic cancer	9.03e-06	0.000467	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—H3F3A—hematologic cancer	8.85e-06	0.000458	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	8.69e-06	0.000449	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—EZH2—hematologic cancer	8.49e-06	0.000439	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—PARP1—hematologic cancer	8.31e-06	0.00043	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—HDAC2—hematologic cancer	8.01e-06	0.000415	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—AR—hematologic cancer	6.95e-06	0.000359	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—CDKN2B—hematologic cancer	6.4e-06	0.000331	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NCOR1—hematologic cancer	6.07e-06	0.000314	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	5.15e-06	0.000267	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—MAPK14—hematologic cancer	4.86e-06	0.000252	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—ESR1—hematologic cancer	4.77e-06	0.000247	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NOTCH1—hematologic cancer	4.61e-06	0.000239	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—CREBBP—hematologic cancer	4.18e-06	0.000216	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.55e-06	0.000132	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—MYC—hematologic cancer	2.48e-06	0.000128	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—AKT1—hematologic cancer	1.72e-06	8.9e-05	CbGpPWpGaD
